EBRO 2017

Treatment options

EBRO 2017

Surgery alone

30-40% potentially resectable

5-20% alive at 3-5 years

pN0 44-57% 5 year survival pN1 13-15% 5 year survival

70% fail with distant metastases

A multimodality approach is necessary to improve the poor results of surgery